These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21888479)
1. Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates. Fathi AR; Pluta RM; Bakhtian KD; Qi M; Lonser RR J Neurosurg; 2011 Dec; 115(6):1213-20. PubMed ID: 21888479 [TBL] [Abstract][Full Text] [Related]
2. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Pluta RM; Dejam A; Grimes G; Gladwin MT; Oldfield EH JAMA; 2005 Mar; 293(12):1477-84. PubMed ID: 15784871 [TBL] [Abstract][Full Text] [Related]
3. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090 [TBL] [Abstract][Full Text] [Related]
4. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672 [TBL] [Abstract][Full Text] [Related]
5. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. Pluta RM; Oldfield EH; Boock RJ J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984 [TBL] [Abstract][Full Text] [Related]
6. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage. Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Woszczyk A; Deinsberger W; Böker DK Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885 [TBL] [Abstract][Full Text] [Related]
8. Effect of an antioxidant, ebselen, on development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Handa Y; Kaneko M; Takeuchi H; Tsuchida A; Kobayashi H; Kubota T Surg Neurol; 2000 Apr; 53(4):323-9. PubMed ID: 10825515 [TBL] [Abstract][Full Text] [Related]
9. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265 [TBL] [Abstract][Full Text] [Related]
10. Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot. Zhang ZD; Yamini B; Komuro T; Ono S; Johns L; Marton LS; Weir B; Macdonald RL Stroke; 2001 Aug; 32(8):1868-74. PubMed ID: 11486119 [TBL] [Abstract][Full Text] [Related]
11. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. Clatterbuck RE; Gailloud P; Ogata L; Gebremariam A; Dietsch GN; Murphy KJ; Tamargo RJ J Neurosurg; 2003 Aug; 99(2):376-82. PubMed ID: 12924713 [TBL] [Abstract][Full Text] [Related]
12. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial. Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471 [TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in a primate model of cerebral vasospasm. Iuliano BA; Pluta RM; Jung C; Oldfield EH J Neurosurg; 2004 Feb; 100(2):287-94. PubMed ID: 15086237 [TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study. Oldfield EH; Loomba JJ; Monteith SJ; Crowley RW; Medel R; Gress DR; Kassell NF; Dumont AS; Sherman C J Neurosurg; 2013 Sep; 119(3):634-41. PubMed ID: 23706046 [TBL] [Abstract][Full Text] [Related]
15. Increased levels of nitrite/nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage. Suzuki M; Asahara H; Endo S; Inada K; Doi M; Kuroda K; Ogawa A Neurosurg Rev; 1999 Oct; 22(2-3):96-8. PubMed ID: 10547005 [TBL] [Abstract][Full Text] [Related]
16. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Aihara Y; Jahromi BS; Yassari R; Sayama T; Macdonald RL Neurosurgery; 2003 Mar; 52(3):661-7; discussion 666-7. PubMed ID: 12590692 [TBL] [Abstract][Full Text] [Related]
17. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage. Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677 [TBL] [Abstract][Full Text] [Related]
18. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo. Fathi AR; Marbacher S; Graupner T; Wehrli F; Jakob SM; Schroth G; Fandino J Acta Neurochir (Wien); 2011 Aug; 153(8):1669-75; discussion 1675. PubMed ID: 21671141 [TBL] [Abstract][Full Text] [Related]